[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339999-105":59,"doc-detail-339999-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","androgen-receptor-monomers-and-dimers-regulate-opposing-biological-processes-in-prostate-cancer-cells","Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells","","Androgen receptor (AR) signaling drives prostate cancer growth, yet current therapeutic strategies based on absolute androgen-axis inhibition face paradoxical challenges: low androgen levels support AR monomer activity, while high doses can yield clinical efficacy in late-stage metastatic disease. The study shows low-dose androgens trigger non-genomic mTOR pathway activation to promote proliferation. In contrast, high-dose androgens promote AR dimer/oligomer formation, suppress c-MYC expression, inhibit proliferation, and activate a differentiated transcriptional program, highlighting liabilities of AR inhibition approaches and informing new therapeutic development.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/androgen-receptor-monomers-and-dimers-regulate-opposing-biological-processes-in-prostate-cancer-cells/339999/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/androgen-receptor-monomers-and-dimers-regulate-opposing-biological-processes-in-prostate-cancer-cells/339999.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do low androgen levels influence prostate cancer cell behavior?","Question",{"text":112,"@type":113},"Low levels of androgens acting through an AR monomer facilitate non-genomic activation of the mTOR signaling pathway, driving proliferation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the effect of high androgen doses in this study?",{"text":117,"@type":113},"High doses promote formation of AR dimers/oligomers, suppress c-MYC expression, inhibit proliferation, and induce a transcriptional program linked to a differentiated phenotype.",{"name":119,"@type":110,"acceptedAnswer":120},"Why do the findings suggest limitations in current androgen/AR inhibition strategies?",{"text":121,"@type":113},"Because AR actions differ by androgen dose and involve distinct receptor states (monomer versus dimer/oligomer), absolute inhibition can miss beneficial or suppressive dose-specific biological processes and may hinder development of effective therapies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339999,1790183694,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article [https://doi.org/10.1038/s41467-024-52032-y](https://doi.org/10.1038/s41467-024-52032-y)  \nAndrogen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells  \nReceived: 4 November 2023  \n\n| Accepted: 23 August 2024 |\n| --- |\n| |\n| Check for updates |\n\nRachid Saﬁ1, Suzanne E. Wardell 1, Paige Watkinson1, Xiaodi Qin 2, Marissa Lee2, Sunghee Park1, Taylor Krebs1, Emma L. Dolan1, Adam Blattler3, Toshiya Tsuji3, Surendra Nayak3, Marwa Khater 4, Celia Fontanillo4, Madeline A. Newlin1, Megan L. Kirkland1, Yingtian Xie5, Henry Long 5, Emma C. Fink 6, Sean W. Fanning 6, Scott Runyon7, Myles Brown 5, Shuichan Xu3, Kouros Owzar2,8, John D. Norris1 & Donald P. McDonnell 1   \nMost prostate cancers express the androgen receptor (AR), and tumor growth and progression are facilitated by exceptionally low levels of systemic or intratumorally produced androgens. Thus, absolute inhibition ofthe androgen signaling axis remains the goal of current therapeutic approaches to treat prostate cancer (PCa). Paradoxically, high dose androgens also exhibit considerable efﬁcacy as a treatment modality in patients with late-stage metastatic PCa. Here we show that low levels of androgens, functioning through an AR monomer, facilitate a non-genomic activation of the mTOR signaling pathway to drive proliferation. Conversely, high dose androgens facilitate the formation ofAR dimers/oligomers to suppress c-MYC expression, inhibit proliferation and drive a transcriptional program associated with a differentiated phenotype. These ﬁndings highlight the inherent liabilities in current approaches used to inhibit AR action in PCa and are instructive as to strategies that can be used to develop new therapeutics for this disease and other androgenopathies.  \nAndrogens, acting through the androgen receptor (AR), are involved in the development of the male reproductive system, manifestation of secondary sex characteristics at puberty, and establishment and maintenance of reproductive function1. They are also key regulators of metabolic homeostasis and processes required for normal skeletal/bone integrity and muscle development/function2–6. Dysregulated responses to AR/androgens are apathogenomic feature of prostate cancer (PCa)7. The primary androgen, testosterone (T), is synthesized de novo in the Leydig cells within the testes and can be transformed to the higher afﬁnity  \nandrogen dihydrotestosterone (DHT) by any of three genetically distinct 5α-reductases (SRD5A1-3)8,9. A long-standing question in developmental biology is how and why some phenotypic responsesin males require only low levels ofT whereas others more associated with differentiated phenotypes require higher levels of this hormone or exposure to DHT10. Similarly, the response of prostate tumors to androgens also differs as a function of dose11,12. These observations suggest that AR-expressing cells must possess mechanisms that enable them to recognize and respond differently to different levels of androgenic ligands13,14.  \n1Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA. 2Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA. 3Oncogenesis Thematic Research Center, Bristol Myers Squibb, San Diego, CA, USA. 4Informatics and Predictive Sciences, Bristol Myers Squibb, San Diego, CA, USA. 5Dana-Farber Cancer Institute, Boston, MA, USA. 6Department of Cancer Biology, Loyola University, Maywood, IL, USA. 7RTI International, Research Triangle Park, NC, USA. 8Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA. e-mail: [Donald.McDonnell@duke.edu](Donald.McDonnell@duke.edu)  \nIn contemporary models ofAR action/pharmacology it is posited that in the absence of ligand, AR resides in the cytoplasm in an inactive form bound toa large multi-factor heat-shock protein (HSP)complex15. Upon binding an agonist, the receptor undergoes a conformational change that ","cbCaikmLJRQaSSpo","https://ap.wps.com/l/cbCaikmLJRQaSSpo","pdf",3859361,"English","# Abstract\n## Key findings: low vs high androgen effects\n## AR structural states: monomers versus dimers/oligomers\n## Mechanistic focus: mTOR activation and c-MYC suppression\n## Therapeutic implications for AR pathway inhibition","[{\"question\":\"How do low androgen levels influence prostate cancer cell behavior?\",\"answer\":\"Low levels of androgens acting through an AR monomer facilitate non-genomic activation of the mTOR signaling pathway, driving proliferation.\"},{\"question\":\"What is the effect of high androgen doses in this study?\",\"answer\":\"High doses promote formation of AR dimers/oligomers, suppress c-MYC expression, inhibit proliferation, and induce a transcriptional program linked to a differentiated phenotype.\"},{\"question\":\"Why do the findings suggest limitations in current androgen/AR inhibition strategies?\",\"answer\":\"Because AR actions differ by androgen dose and involve distinct receptor states (monomer versus dimer/oligomer), absolute inhibition can miss beneficial or suppressive dose-specific biological processes and may hinder development of effective therapies.\"}]","Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells | PDF",1790033596,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2a14b424d13d46df2494d0e078e15e3.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ab2577857c516a279b2d5ac77fb9b5a.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d21e0f9265e809ddace0bc2a8ca7b76.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c299e2ec698441023c72bdc62138a05.webp",980,1301]